Cargando…
Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity
Adoptive T cell transfer therapy, the ex vivo activation, expansion, and subsequent administration of tumor-reactive T cells, is already the most effective therapy against certain types of cancer. However, recent evidence in animal models and clinical trials suggests that host conditioning intervent...
Autores principales: | Nesbeth, Yolanda, Conejo-Garcia, Jose R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975067/ https://www.ncbi.nlm.nih.gov/pubmed/21076522 http://dx.doi.org/10.1155/2010/139304 |
Ejemplares similares
-
Harnessing allogeneic CD4(+) T cells to reinvigorate host endogenous antitumor immunity
por: Mochizuki, Kazuhiro
Publicado: (2023) -
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021) -
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
por: Lee, Ping-Hsien, et al.
Publicado: (2019) -
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
por: Fereydouni, Mohammad, et al.
Publicado: (2022) -
Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
por: Silverio, Kimberly A., et al.
Publicado: (2017)